The Government of Singapore bought shares worth Rs 288 crore in PG Electroplast via a block deal on Tuesday. It bought over 38.18 lakh shares at a price of Rs 754.80 per share which is a 2% discount over the Monday closing price of Rs 771.55.
In another block deal, BNP Paribas Financial Markets bought nearly 3 lakh shares worth Rs 10 crore in smallcap counter Suraksha Diagnostic. The asset management arm of French multinational bank BNP Paribas purchased shares at a price of Rs 338 per share, up by 0.9% over the previous losing price.
PG Electroplast is a diversified EMS player in India and offers comprehensive ODM and OEM solutions to 60+ Indian and global brands across the consumer electronics and consumer durables industries. Its product line includes air conditioners, washing machines, LED television and air coolers.
PG Electroplast is a smallcap multibagger and has delivered returns of 200% over the past 12 months. However, the stock has been under consolidation and has corrected by 25% in 2025 so far.
The recent correction has brought it below its 50-day simple moving average of Rs 867 while it is still trading above its 200-day SMA of Rs 753. The stock has been quite volatile and has traded with a 1-year beta of 1.8.
PG Electroplast reported a consolidated net profit of Rs 145 crore in Q4FY25 which was up from 70 crore posted by the company in the year ago period, recording a 107% year-on-year growth. Total revenue in the quarter under review stood at Rs 1,930 crore, up 79% over Rs 1,080 crore reported in the corresponding quarter of the last financial year.
Also Read: Goldman Sachs buys shares worth Rs 50 crore in this smallcap stock via block deal
Meanwhile, December listed Suraksha Diagnostic is a Kolkata-based pathology and radiology services company which has presence in eastern and north-eastern India. The stock has fallen 21% since its listing while plunging 14% on a year-to-date basis. The stock is currently trading above its 50-day SMA.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)
In another block deal, BNP Paribas Financial Markets bought nearly 3 lakh shares worth Rs 10 crore in smallcap counter Suraksha Diagnostic. The asset management arm of French multinational bank BNP Paribas purchased shares at a price of Rs 338 per share, up by 0.9% over the previous losing price.
PG Electroplast is a diversified EMS player in India and offers comprehensive ODM and OEM solutions to 60+ Indian and global brands across the consumer electronics and consumer durables industries. Its product line includes air conditioners, washing machines, LED television and air coolers.
PG Electroplast is a smallcap multibagger and has delivered returns of 200% over the past 12 months. However, the stock has been under consolidation and has corrected by 25% in 2025 so far.
The recent correction has brought it below its 50-day simple moving average of Rs 867 while it is still trading above its 200-day SMA of Rs 753. The stock has been quite volatile and has traded with a 1-year beta of 1.8.
PG Electroplast reported a consolidated net profit of Rs 145 crore in Q4FY25 which was up from 70 crore posted by the company in the year ago period, recording a 107% year-on-year growth. Total revenue in the quarter under review stood at Rs 1,930 crore, up 79% over Rs 1,080 crore reported in the corresponding quarter of the last financial year.
Also Read: Goldman Sachs buys shares worth Rs 50 crore in this smallcap stock via block deal
Meanwhile, December listed Suraksha Diagnostic is a Kolkata-based pathology and radiology services company which has presence in eastern and north-eastern India. The stock has fallen 21% since its listing while plunging 14% on a year-to-date basis. The stock is currently trading above its 50-day SMA.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)
